Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062737) titled 'Efficacy and safety of 0.5% epinastine ophthalmic solution cream in patients of allergic conjunctivitis' on Sept. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Tsurumi University
Condition:
Condition - Patients with allergic conjunctivitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Efficacy of 0.5% epinastine ophthalmic solution cream
Basic objectives2 - Safety
Eligibility:
Age-lower limit - 1
years-old
=
Gender - Male and Female
Key inclusion criteria - Patients who received a full explanation on the objects and methods of this study, expected e...